Union Rep, Retirement Policy Scholar On W&M Drug-Price Witness List

By Rachel Cohrs / February 11, 2019 at 3:06 PM
The House Ways & Means Committee’s drug-pricing hearing on Tuesday (Feb. 12) will likely include labor perspectives, based on the witness list. The panel features a United Auto Workers representative, in addition to a retirement policy expert, a cancer and double-transplant survivor, and a mix of left- and right-leaning scholars. The structure is similar to two previous hearings this session in the House Oversight & Government Reform and Senate Finance committees, though those focused on rising insulin prices. The panelists...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.